Skip to content
Screener

Roivant Sciences ROIV Shares (Diluted)

Discontinued — last reported Q4 '25

Shares (Diluted) at other companies

Amgen logo
AmgenAMGN
544M+0.6%
Moderna logo
ModernaMRNA
398M+2.6%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
182.4M+20.4%
AbbVie logo
AbbVieABBV
1.8B0.0%
Regenxbio logo
RegenxbioRGNX
52.4M+1.9%
CNT
Canton Strategic Holdings IncCNTN
207.7M+7,973%

Other financials

Income statement

See full
Revenue$2.5M-66.7%
Operating income-$339.2M-23.6%
Net income-$265.9M-257%
EPS (diluted)-$0.38-265%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Market cap$24.5B+212%
Enterprise value$23.19B+195%
P/S2,965.7×+2,628×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-9,183.5%-17,093pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Roivant Sciences’s 10-K, filed May 20, 2026.

Filed
May 20, 2026, 7:17 AM EDT
Fiscal year
FY2025
Accession
0001635088-26-000061
Line itemYears Ended March 31, 2026Years Ended March 31, 2025Years Ended March 31, 2024
Net (loss) income$(0.43)$(0.24)$5.55
Net (loss) income per common share, diluted:
(Loss) income from continuing operations, net of tax$(0.54)$(0.75)$5.61
Income (loss) from discontinued operations, net of tax$0.51$(0.38)
Net (loss) income$(0.54)$(0.24)$5.23
Weighted average shares outstanding:
Basic693,864,530725,395,624783,248,906
Diluted693,864,530725,395,624831,049,444

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Roivant Sciences's shares (diluted)?
Roivant Sciences (ROIV) reported shares (diluted) of 693.9M in Q1 2026.
How has Roivant Sciences's shares (diluted) changed year-over-year?
Roivant Sciences's shares (diluted) decreased by 4.3% year-over-year, from 725.4M to 693.9M.
What is the long-term trend for Roivant Sciences's shares (diluted)?
Over 4 years (2021 to 2025), Roivant Sciences's shares (diluted) has grown at a 0.9% compound annual growth rate (CAGR), from 2.7B to 2.8B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Roivant Sciences's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude